PrognomiQ

About:

PrognomiQ is a biotechnology firm that develops test products to detect early disease detection through the power of multi-omics data.

Website: https://prognomiq.com

Twitter/X: PrognomiQ_Inc

Top Investors: Fidelity, Seer, Invus, Bruker, Wing Venture Capital

Description:

PrognomiQ is a technology company that focuses on transforming early disease detection and treatment through multi-omics data. The company generates extensive proteomic, genomic, and metabolomic data to provide insights into complex diseases, aiming to improve patient outcomes. PrognomiQ's innovative approach facilitates the development of advanced test products that enhance the understanding and management of health conditions.